Filing Details

Accession Number:
0001209191-10-023993
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-28 13:00:00
Reporting Period:
2010-04-26
Filing Date:
2010-04-28
Accepted Time:
2010-04-28 15:40:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1097136 Senorx Inc SENO Surgical & Medical Instruments & Apparatus (3841) 330787406
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1134655 Ansbert Gadicke C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1134657 Luke Evnin C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1166285 Michael Steinmetz C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1252522 Nicholas Galakatos C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1264824 Mpm Asset Management Investors 2001 Llc C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1264826 Mpm Asset Management Ii Lp C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1264827 Mpm Asset Management Ii Llc C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1264829 Mpm Bioventures Ii Lp C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1264830 Mpm Bioventures Ii Qp Lp C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1264832 Mpm Bioventures Gmbh & Co Parallel Beteiligungs Kg C/O Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-04-26 1,000 $10.05 2,207,668 No 4 S Indirect See footnote
Common Stock Disposition 2010-04-27 13,900 $10.09 2,193,768 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The shares were sold as follows: 674 by MPM BioVentures II-QP, L.P. ("BV II QP"), 75 by MPM BioVentures II, L.P. ("BV II"), 14 by MPM Asset Management Investors 2001 LLC ("AM 2001") and 237 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG ("BV KG"). MPM Asset Management II, L.P. ("AM II GP") and MPM Asset Management II LLC ("AM II LLC") are the direct and indirect general partners of BV II QP, BV II and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Michael Steinmetz and Kurt Wheeler are the members of AM II LLC and AM 2001.
  2. The shares are held as follows: 1,488,412 by BV II QP, 164,250 by BV II, 30,906 by AM 2001 and 524,100 by BV KG. Each member of the group disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.
  3. The shares were sold as follows: 9,371 by BV II QP, 1,034 by BV II, 195 by AM 2001 and 3,300 by BV KG.
  4. The shares are held as follows: 1,479,041 by BV II QP, 163,216 by BV II, 30,711 by AM 2001 and 520,800 by BV KG. Each member of the group disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.